行情

AVGR

AVGR

Avinger
NASDAQ

实时行情|Nasdaq Last Sale

1.150
+0.050
+4.55%
已收盘, 19:51 09/18 EDT
开盘
1.130
昨收
1.100
最高
1.220
最低
1.100
成交量
284.77万
成交额
--
52周最高
15.10
52周最低
1.040
市值
1,177.01万
市盈率(TTM)
-0.1057
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

AVGR 新闻

  • 日本据悉在推迟向韩国出口芯片生产的关键材料
  • 新浪财经综合.1小时前
  • 沪指尾盘拉升 美联储宣布降息、美股先抑后扬
  • 新浪财经.1小时前
  • 瑞士央行将利率维持在负值区域,并下调经济增长预期
  • 环球外汇网官网.1小时前
  • 历史上的两次大崩盘,罪魁祸首竟然都是金融创新!
  • 新浪财经-自媒体综合.1小时前

更多

所属板块

先进医疗设备和技术
+0.54%
医疗设备和用品
+0.41%

热门股票

名称
价格
涨跌幅

AVGR 简况

Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The Company focuses on introducing products based on its lumivascular platform, which is an intravascular image-guided system. The Company manufactures and sells a suite of products in the United States and certain European markets. The Company's products include Lightbox imaging console, as well as its Wildcat, Kittycat and the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO). The lumivascular platform offers real-time visualization of the inside of the artery during PAD treatment. The lumivascular platform consists of a capital component Lightbox and a range of disposable catheter products, including Ocelot, Ocelot PIXL, Ocelot MVRX and Pantheris.
展开

Webull提供Avinger Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。